The Globe and Mail reports in its Tuesday, May 9, edition that TD Securities analyst Michael Tupholme is sticking with his "hold" recommendation for Nutrien. The Globe's David Leeder writes in the Eye On Equities column that Mr. Tupholme cut his share target back by $8 (U.S.) to $80 (U.S.). Analysts on average target the shares at $92.85 (U.S.). Mr. Tupholme says in a note: "Since Nutrien reported Q4/22 results in mid-February, benchmark fertilizer prices have been mixed (although, in terms of impact, relevant price declines have outpaced the extent to which certain prices have risen/held steady, in our assessment). In the U.S., urea prices have rallied and potash prices have been flattish (both seen benefiting from spring demand). However, ammonia prices have declined sharply, while phosphate prices and offshore potash prices have continued to trend lower. We have made a variety of adjustments to our model. Overall, our estimates for both Q1/23 and subsequent quarters have declined." The Globe reported on April 11 that Scotia Capital's Ben Isaacson had upgraded Nutrien to "sector outperform" from "sector perform." The shares could then be had for $73.30 (U.S.).